Active Substance: Vibrio cholera Inaba, Vibrio cholera Inaba E1 Tor, Vibrio cholera Ogawa, Vibrio cholera Ogawa E1 Tor.
Overview
Welcome to Dwaey, specifically on CHOLERA BERNA VACCINE page.
This medicine contains an important and useful components, as it consists of
Vibrio cholera Inaba, Vibrio cholera Inaba E1 Tor, Vibrio cholera Ogawa, Vibrio cholera Ogawa E1 Toris available in the market in concentration
Oral Cholera Vaccine (Vibrio cholerae 01 Inaba & Ogawa strains)
Immunisation should be delayed in patients suffering from acute febrile illness or acute GI illness. Not recommended for use in children <2 yr. Limited data on efficacy and safety of the vaccine usage in HIV-infected patients. Additional protective measures should be undertaken as the vaccine does not provide complete protection against cholera infection.
Cholera, Protection against cholera in adult & children >2 yr.
Hypersensitivity. Acute stomach disorder or infection w/ fever (postpone vaccination).
GI disturbances, headache, dizziness and respiratory symptoms. Fever and malaise, hypersensitivity reactions and neurological symptoms.
0
Cholera vaccine is available as oral preparations containing either live attenuated or inactivated strains. Oral cholera vaccines appear to be more effective than parenteral vaccines. It may be used in adults and children aged ?2 yr who are traveling to areas of risk.
Not to be used within 3 wk of immunoglobulin admin. Reduced response may occur in patients who are concurrently receiving immunosuppressant treatment e.g. antineoplastics, corticosteroids at therapeutic doses. Oral, encapsulated typhoid vaccine should not be admin within 8 hr of cholera vaccine admin.
Information not available